Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

DiaMedica Therapeutics Inc DMAC

DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate DM199 (rinvecalinase alfa) is the first pharmaceutically active recombinant (synthetic) form of the human tissue kallikrein-1 (KLK1) protein to be clinically studied in patients. KLK1 is an established therapeutic modality in Asia, with human urinary KLK1, for the treatment of acute ischemic stroke and cardio renal disease, including hypertension. It has also produced a potential novel treatment for severe inflammatory diseases, DM300, which is in the early preclinical stage of development. KLK1 is a serine protease, or protein, produced primarily in the kidneys, pancreas and salivary glands. KLK1 plays a critical role in the regulation of local blood flow and vasodilation in the body, as well as an important role in reducing inflammation and oxidative stress.


NDAQ:DMAC - Post by User

Bullboard Posts
Comment by TrueNorth911on Dec 10, 2018 10:08pm
71 Views
Post# 29095001

RE:RE:RE:Upset, dissapointed and betrayed.

RE:RE:RE:Upset, dissapointed and betrayed. Couldn't agree more.

I also believe there was a concerted and co-ordinated effort by some disgruntled legacy shareholders to ruin the coming out for DMAC, thanks to liquidity now available on NASDAQ. Well.. muted short-term outcome, and the horses are out of the stable and we'll retrace their comical mis-steps shortly. Hit the ROADxxx# miss-fired. Giving away the golden tickets. SOMEONE is buying it ALL up at discounted prices. And with any luck, their clients will shortly file a class-action for front-running. No-one sell's off 20M pre-consolidation shares in a single day without a co-ordinated and planned effort. SEC are you watching? Hello? Easy to see where this is coming from, too easy actually.

Every share that get's dumped I'm eagerly and greedily picking up!...thank you dumbsters.
I can take ALL you have to dumb...errr, dump...easily and graciously. Damn...at these prices I can just buy DMAC outright, would be easier. 

The bankers, institutions, myself and many others are just scooping up what they throw out, thank you for the early Xmas gifts, much appreciated.

TRUENorth Strong and DMAC Long.

Bullboard Posts